Ruedi E Waeger - Net Worth and Insider Trading
Ruedi E Waeger Net Worth
The estimated net worth of Ruedi E Waeger is at least $9 Million dollars as of 2024-10-03. Ruedi E Waeger is the Director of Alexion Pharmaceuticals Inc and owns about 48,108 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $9 Million. Details can be seen in Ruedi E Waeger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ruedi E Waeger has not made any transactions after 2010-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ruedi E Waeger
Ruedi E Waeger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ruedi E Waeger owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Ruedi E Waeger’s form 4 insider trades.
Insider Ownership Summary of Ruedi E Waeger
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2010-05-03 | director |
Ruedi E Waeger Latest Holdings Summary
Ruedi E Waeger currently owns a total of 1 stock. Ruedi E Waeger owns 48,108 shares of Alexion Pharmaceuticals Inc (ALXN) as of May 3, 2010, with a value of $9 Million.
Latest Holdings of Ruedi E Waeger
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2010-05-03 | 48,108 | 182.50 | 8,779,710 |
Holding Weightings of Ruedi E Waeger
Ruedi E Waeger Form 4 Trading Tracker
According to the SEC Form 4 filings, Ruedi E Waeger has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the acquisition of 6,000 shares on May 3, 2010, which cost Ruedi E Waeger around $165,300.
Insider Trading History of Ruedi E Waeger
- 1
Ruedi E Waeger Trading Performance
GuruFocus tracks the stock performance after each of Ruedi E Waeger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ruedi E Waeger is 2.95%. GuruFocus also compares Ruedi E Waeger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ruedi E Waeger within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ruedi E Waeger's insider trading performs compared to the benchmark.
Performance of Ruedi E Waeger
Ruedi E Waeger Ownership Network
Ruedi E Waeger Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Ruedi E Waeger is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Ruedi E Waeger Mailing Address
Above is the net worth, insider trading, and ownership report for Ruedi E Waeger. You might contact Ruedi E Waeger via mailing address: C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire Ct 06410.